American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Use of Apremilast.

We read with great interest the recently published American College of Rheumatology (ACR) guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic (1). We greatly appreciate this effort by the ACR which will help rheumatologists optimize management of rheumatic illnesses during the coronavirus disease 2019 (COVID-19) pandemic. We would like to make an important addition to this "living document", and hope this to be addressed in future updates as more data becomes available.